MedPath

Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions

Not Applicable
Active, not recruiting
Conditions
Prostate Cancer
Registration Number
NCT06126172
Lead Sponsor
Chang Gung Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
Male
Target Recruitment
125
Inclusion Criteria

Inclusion Criteria:<br><br> 1. Aged over 20 years old.<br><br> 2. Suspected or confirmed prostate cancer.<br><br> 3. Undergoing prostate mpMRI before clinical treatment.<br><br> 4. Normal renal function(i.e.: estimated GFR ?60).<br><br> 5. No allergy history to gadolinium based contrast agent.<br><br> 6. Agree to participate this study and sign informed consent.<br><br>Exclusion Criteria:<br><br> 1. mpMRI photography not completed.<br><br> 2. mpMRI images are damaged or poor in quality and cannot be interpreted.<br><br> 3. Without pathological examination confirmed prostate cancer.<br><br> 4. Patient withdraw informed consent.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MR characteristics assessment-T2WI;MR characteristics assessment- DWI;MR characteristics assessment- ADC
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath